Peter Wen is a seasoned finance professional with extensive experience in healthcare equity analysis and investment management. Since October 2010, Peter has served as a Director Equity Analyst at Schroders Investment Management, focusing on analyzing and investing across all healthcare sub-sectors while emphasizing product value creation and ROI. Prior to this, Peter worked at AG ASSET MANAGEMENT from 2004 to 2009 as a Healthcare Equity Analyst, contributing to a team that specialized in small to large-cap growth healthcare companies. Between 1999 and 2004, Peter managed various healthcare funds at CREDIT SUISSE ASSET MANAGEMENT and provided recommendations for a significant healthcare equity portfolio. Earlier in the career, Peter was a Large/Mid Cap Healthcare Research Analyst at LYNCH & MAYER, INC., where analytical skills were honed through detailed modeling and valuation work. Peter holds an MBA in Finance from The Wharton School and a Bachelor of Arts in Biology from Harvard University.
This person is not in any offices